Title: Oligonucleotide Compositions with Enhanced Efficacy. Number: 20040054155. Filed: Oct. 2, 2003. Lead Inventor: Tod Woolf, Sequitur (Invitrogen).
The patent application, its abstract states, covers “oligonucleotide compositions [that] … make use of combinations of oligonucleotides. In one aspect, the invention features an oligonucleotide composition including at least two different oligonucleotides targeted to a target gene.”